Hos patienter med ankyloserende spondylitis blev der påvist antistoffer hos 17/ 204 patienter (8, 3%) behandlet med adalimumab.
r ge In patients with ankylosing spondylitis antibodies were identified in 17/ 204 subjects (8.3%) treated with adalimumab.